Tag: ATS

cystic fibrosis lungs
Respiratory

CF Patients Experience Improved Lung Health with Lumacaftor-Ivacaftor But with Caveats

In adolescent and adult patients with cystic fibrosis taking lumacaftor-ivacaftor (ORKAMBI®), the combination drug appears to improve lung function and body weight and reduce the need for intravenous antibiotic treatment, according to a French study published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. However, […]

banned
Respiratory

Michigan Governor Bans All Flavored Vaping Products

The American Thoracic Society applauds Michigan Governor Gretchen Whitmer’s decision to ban the sale of all flavored e-cigarette and vaping products in the state of Michigan. Governor Whitmer’s decision is an appropriate response to the 215 recently reported cases of e-cigarette triggered acute illnesses that have resulted in hospitalization and in at […]

microscope
Industry News Patient Health Professional Practice

New ATS Clinical Practice Guideline: Diagnosing Fungal Infections

The American Thoracic Society has published an official clinical guideline on laboratory diagnosis of fungal infections in pulmonary and critical care medicine in the Society’s Aug. 30 American Journal of Respiratory and Critical Care Medicine. Though less common than bacterial and viral infections, fungal infections have surged in recent decades and […]